MCID: CMP058
MIFTS: 36

Complex Regional Pain Syndrome Type 1 malady

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Complex Regional Pain Syndrome Type 1

About this section
Sources:
51Orphanet, 65UMLS, 28ICD10 via Orphanet
See all MalaCards sources

Aliases & Descriptions for Complex Regional Pain Syndrome Type 1:

Name: Complex Regional Pain Syndrome Type 1 51
Reflex Sympathetic Dystrophy 51 65
 
Algodystrophic Syndrome 65
Algodystrophy 51

Characteristics:

Orphanet epidemiological data:

51
reflex sympathetic dystrophy:
Age of onset: All ages

Classifications:



External Ids:

Orphanet51 99995
ICD10 via Orphanet28 M89.0
UMLS65 C1527353

Summaries for Complex Regional Pain Syndrome Type 1

About this section
MalaCards based summary: Complex Regional Pain Syndrome Type 1, also known as reflex sympathetic dystrophy, is related to meige syndrome and brain ischemia. An important gene associated with Complex Regional Pain Syndrome Type 1 is TNF (Tumor Necrosis Factor), and among its related pathways are African trypanosomiasis and IL-10 Pathway. Affiliated tissues include bone, cortex and prostate.

Related Diseases for Complex Regional Pain Syndrome Type 1

About this section

Diseases in the Complex Regional Pain Syndrome family:

complex regional pain syndrome type 1

Diseases related to Complex Regional Pain Syndrome Type 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 219)
idRelated DiseaseScoreTop Affiliating Genes
1meige syndrome30.7IL6, TNF
2brain ischemia30.5EDN1, IL6
3pneumoconiosis30.5IL6, TNF
4hyperglycemia29.9IL6, TNF
5reflex sympathetic dystrophy13.0
6complex regional pain syndrome12.1
7algoneurodystrophy12.0
8breast cancer10.4
9ischemia10.4
10neuronitis10.4
11plantar nerve lesion10.3IL6, TNF
12malignant sertoli-leydig cell tumor of ovary10.3IL6, TNF
13mammary paget's disease10.3IL6, TNF
14lujo hemorrhagic fever10.3IL6, TNF
15posterior valve urethra10.3IL6, TNF
16t cell immunodeficiency primary10.3IL6, TNF
17residual stage angle-closure glaucoma10.3IL6, TNF
18parovarian cyst10.3IL6, TNF
19precursor b lymphoblastic lymphoma/leukemia10.3IL6, TNF
20collagenous colitis10.3IL6, TNF
21paranoid schizophrenia10.3IL6, TNF
22ischemic optic neuropathy10.3IL6, TNF
23refractory plasma cell neoplasm10.3IL6, TNF
24early-onset, autosomal dominant alzheimer disease10.3IL6, TNF
25skin conditions10.3IL6, TNF
26tick-borne relapsing fever10.3IL6, TNF
27postsurgical hypothyroidism10.3IL6, TNF
28streptococcal meningitis10.3IL6, TNF
29hemorrhagic proctocolitis10.3IL6, TNF
30dancing eyes-dancing feet syndrome10.3IL6, TNF
31hemolytic anemia10.3IL6, TNF
32diffuse intraductal papillomatosis10.3IL6, TNF
33rubeosis iridis10.3IL6, TNF
34ureteral disease10.3IL6, TNF
35duodenum cancer10.3IL6, TNF
36idiopathic spinal cord herniation10.3IL6, TNF
37dentin caries10.3IL6, TNF
38placental abruption10.3IL6, TNF
39secretory diarrhea10.3IL6, TNF
40hypopharynx cancer10.3IL6, TNF
41vagus nerve neoplasm10.3IL6, TNF
42basilar artery occlusion10.3IL6, TNF
43submandibular gland disease10.3IL6, TNF
44cholera10.3IL6, TNF
45periodontal disease10.3IL6, TNF
46chagas disease10.3CALCA, TNF
47constant exophthalmos10.3IL6, TNF
48lung cancer10.3
49hepatitis10.3
50hydrocephalus10.3

Graphical network of the top 20 diseases related to Complex Regional Pain Syndrome Type 1:



Diseases related to complex regional pain syndrome type 1

Symptoms for Complex Regional Pain Syndrome Type 1

About this section

Drugs & Therapeutics for Complex Regional Pain Syndrome Type 1

About this section

Drugs for Complex Regional Pain Syndrome Type 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 48)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Salmon Calcitoninapproved, investigationalPhase 45047931-85-116129616
Synonyms:
135506-95-5
47931-85-1
Astronin
Biocalcin
Bionocalcin
C028815
C06865
C145H239N43O48S2
CALCITONIN, SALMON
Cadens
Calciben
Calcihexal
Calcimar
Calcimar (TN)
Calcimonta
Calcinil
Calcioton
Calcitonin (Salmon Synthetic)
Calcitonin (salmon)
Calcitonin 1 precursor
Calcitonin Salmon
Calcitonin [USAN:INN:BAN:JAN]
Calcitonin salmon
Calcitonin salmon (USAN/INN)
Calcitonin salmon (synthesis)
Calcitonin salmon (synthesis) (JAN)
Calcitonin vom lachs
Calcitonin, salmar
Calcitonin, salmon
Calcitonin, salmon, for bioassay
Calcitonin,salmon
Calcitonin-salmon
Calcitonina
Calcitonine de saumon
Calcitoran
Calco
Calogen
Calsynar
Calsynar Lyo L
Caltine
Casalm
Catonin
Cibacalcin
Cibacalcine
Citonina
 
D00249
EINECS 256-342-8
Eptacalcin
Forcaltonin
Fortical
Fortical (TN)
Ipocalcin
Isi-calcin
Kalsimin
Karil
LS-48624
Miacalcic
Miacalcin
Miacalcin (TN)
Miracalcic
Oseototal
Osseocalcina
Osteobion
Osteovis
Ostosalm
Ostostabil
Porostenina
Prontocalcin
Quosten
Riostin
Rulicalcin
Salcat
Salcatonin
Salcatyn
Salmocalcin
Salmofar
Salmon calcitonin
Salmon calcitonin I
Salmon calcitonin-(I-32)
Salmotonin
Sical
Stalcin
Staporos
Steocin
TZ-CT
Thyrocalcitonin (salmon)
Tonocalcin
UNII-7SFC6U2VI5
Ucecal
recombinant salmon calcitonin
salmon calcitonin (1-32)
synthetic salmon calcitonin
2
Vitamin Capproved, nutraceuticalPhase 4, Phase 342450-81-75785, 54670067
Synonyms:
(+)-Sodium L-ascorbate
(+)-ascorbate
(+)-ascorbic acid
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
3-Keto-L-gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
30208-61-8
33034_RIEDEL
33034_SIAL
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AA
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
AR-1J3435
Acid Ascorbic
Acide ascorbique
Acide ascorbique [INN-French]
Acido ascorbico
Acido ascorbico [INN-Spanish]
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
Antiscorbic Vitamin
Antiscorbic vitamin
Antiscorbutic Vitamin
Antiscorbutic factor
Antiscorbutic vitamin
Arco-Cee
Arco-cee
Ascoltin
Ascoltin (TN)
Ascor-B.I.D.
Ascorb
Ascorbajen
Ascorbate
Ascorbic Acid
Ascorbic Acid, Monosodium Salt
Ascorbic acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
BPBio1_000363
BSPBio_000329
Babor Baborganic Biological Enzyme Cleanser
C-Level
C-Long
C-Quin
C-Span
C-Vimin
C00072
C6H8O6
CCRIS 57
CE-VI-Sol
CHEBI:29073
CHEMBL196
CID5785
Cantan
Cantaxin
Caswell No. 061B
Catavin C
Ce Lent
Ce lent
Ce-Mi-Lin
Ce-mi-lin
Ce-vi-sol
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-Caps TD
Cee-Caps Td
Cee-Vite
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-Caps TC
Cetane-Caps TD
Cetane-Caps Tc
Cetane-Caps Td
Cetane-caps TC
Cetane-caps TD
Cetebe
 
Cetemican
Cevalin
Cevatine
Cevex
Cevi-Bid
Cevi-bid
Cevimin
Cevital
Cevitamate
Cevitamic Acid
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
Ciamin
Cipca
Citriscorb
Citrovit
Colascor
Concemin
Cortalex
D00018
DB00126
Davitamon C
Dora-C-500
Duoscorb
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
HSDB 818
HiCee
Hicee
Hybrin
IDO-C
Ido-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina Askorbova
Kyselina askorbova
Kyselina askorbova [Czech]
L(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbate
L-(+)-Ascorbic Acid
L-(+)-Ascorbic acid
L-(+)-ascorbic acid
L-3-Ketothreohexuronic acid lactone
L-3-ketothreohexuronic acid
L-Ascorbate
L-Ascorbic Acid
L-Ascorbic acid
L-Ascorbic acid, free radical form
L-Lyxoascorbate
L-Lyxoascorbic Acid
L-Lyxoascorbic acid
L-Threo-ascorbic acid
L-Threoascorbic acid
L-Xyloascorbate
L-Xyloascorbic Acid
L-Xyloascorbic acid
L-ascorbate
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-ascorbic acid
L-threo-hex-2-enono-1,4-lactone
LS-145
Laroscorbine
Lemascorb
Liqui-Cee
Liqui-cee
MLS002153776
Magnesium Ascorbicum
Magnorbin
Meri-C
Meri-c
MolPort-001-792-501
Monodehydroascorbic acid
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
NCI-C54808
NSC 33832
Natrascorb
Natrascorb injectable
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
SMR001233160
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Sodascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100M
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamin- C
Vitamin-?C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
antiscorbic vita min
ascor-b.i.d
ascorbate
ascorbic acid
bmse000182
cee-caps td
cevibid
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
e 300
e-300
e300
gamma-Lactone L-threo-Hex-2-enonate
gamma-Lactone L-threo-Hex-2-enonic acid
l-ascorbic acid
l-threo-hex-1-eofuranos-3-ulose
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
roscorbi c
vitamin C
3calcitoninPhase 450
4Calcitonin Gene-Related PeptidePhase 450
5Bone Density Conservation AgentsPhase 4, Phase 3, Phase 22600
6Vasodilator AgentsPhase 4, Phase 22926
7VitaminsPhase 4, Phase 33857
8MicronutrientsPhase 4, Phase 33901
9AntioxidantsPhase 4, Phase 32442
10Protective AgentsPhase 4, Phase 35651
11Trace ElementsPhase 4, Phase 33900
12
Zoledronic acidPhase 3286118072-93-868740
Synonyms:
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid
(1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate
118072-93-8
2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid
2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
AC-1092
AC1L2ACJ
AC1Q6RN3
AKOS005145739
Aclasta
BIDD:GT0292
BIDD:PXR0134
Bio-0112
Bisphosphonate 3
C088658
CGP 42'446
CGP 42446
CGP 42446A
CGP-42'446
CGP-42446
CHEBI:46557
CHEMBL924
CID68740
D08689
 
DB00399
FT-0082657
HMS2089O09
I06-0710
KS-1132
LS-181815
MolPort-002-885-874
MolPort-003-850-890
NCGC00159521-02
NCGC00159521-03
NSC721517
Novartis brand of zoledronic acid
Reclast
Reclast (TN)
S00092
S1314_Selleck
UNII-70HZ18PH24
ZOL
Zoledronate
Zoledronic acid
Zoledronic acid (INN)
Zoledronic acid [USAN:INN]
Zometa
Zometa (Novartis)
Zometa (TN)
Zometa Concentrate
Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)
13DiphosphonatesPhase 2, Phase 3381
14Rho(D) Immune GlobulinPhase 3206
15AntibodiesPhase 34477
16Immunologic FactorsPhase 3, Phase 218483
17Immunoglobulins, IntravenousPhase 3211
18ImmunoglobulinsPhase 34477
19
ClonidineapprovedPhase 21894205-90-72803
Synonyms:
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-dichloro-N-imidazolidin-2-ylideneaniline
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-Dichlorophenylimino)imidazolidine
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00514634
AC1L1EI5
AC1Q3K6V
AKOS001595470
Adesipress
BIDD:GT0547
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
C9H9Cl2N3
CAS-4205-91-8
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
CID2803
Catapres
Catapres- TTS
Catapres-TTS
Catapresan
Catapressan
Catarpres
Catarpres-TTS
Catarpres-TTS (TN)
Catarpresan
Chlofazoline
Chlornidinum
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
Clonidine
Clonidine (JAN/USAN/INN)
Clonidine HCl
Clonidine Hydrochloride
Clonidine Transdermal System
Clonidine [USAN:BAN:INN]
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
D00281
DB00575
DB07566
DivK1c_000774
 
Dixarit
Duraclon
Duraclont
EINECS 224-119-4
Gemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HSDB 3040
Hemiton
IDI1_000774
IDI1_034058
Ipotensium
Isoglaucon
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Kapvay
Klofelin
Klofenil
L000193
LS-79606
Lopac-C-7897
Lopac0_000268
M 5041T
M-5041T
MolPort-001-779-668
MolPort-005-932-374
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
NINDS_000774
Nexiclon
Nexiclon Xr
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SKF 34427
SPBio_001233
SPBio_002255
ST 155BS
ST-155-BS
ST-155BS
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
Spectrum_001341
T171
Tenso-Timelets
Tocris-0690
UNII-MN3L5RMN02
ZINC00896484
clonidine
nchembio.79-comp11
nchembio705-10
20
LenalidomideapprovedPhase 2674191732-72-6216326
Synonyms:
1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline
191732-72-6
3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione
3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
346670-73-3
443912-14-9
AC-914
AC1L50II
AKOS005146276
ALBB-015321
Bio-0168
C467567
CC 5013
CC-5013
CC-5013, Revlimid, Lenalidomide
CC5013
CDC 501
CDC-501
CDC-5013
CHEMBL848
CID216326
Celgene brand of lenalidomide
D04687
 
DB00480
EC-000.2340
ENMD-0997
I06-0831
IMID-1
IMID-5013
IMiD3
IMiD3 cpd
IMid-1
LS-184040
Lenalidomide
Lenalidomide (USAN/INN)
Lenalidomide [USAN]
MolPort-003-848-370
NCGC00167491-01
NSC747972
Revamid
Revimid
Revlimid
Revlimid (Celgene)
Revlimid (TN)
S1029_Selleck
STK639603
Thalidomide analog CC-5013
UNII-F0P408N6V4
lenalidomide
21
Adenosineapproved, investigationalPhase 236358-61-760961
Synonyms:
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose
1odi
2fqy
2gl0
30143-02-3
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside
46946-45-6
46969-16-8
58-61-7
6-Amino-9-.beta.-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-delta-ribofuranosyl-9H-purine
9-(beta-D-Arabinofuranosyl)adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-Ribofuranosidoadenine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyladenine
9beta-D-Ribofuranosyladenine
9beta-D-ribofuranosyl-9H-Purin-6-amine
9beta-delta-Ribofuranosyladenine
9beta-delta-ribofuranosyl-9H-Purin-6-amine
A0152
A4036_SIGMA
A9251_SIGMA
AC1L1U8O
AC1Q1ID3
AC1Q52XU
ADN
AI3-52413
Ade-Rib
Ade-rib
Adenin riboside
Adenine 9-beta-D-arabinofuranoside
Adenine deoxyribonucleoside
Adenine nucleoside
Adenine riboside
Adenine-9-beta-D-ribofuranoside
Adenine-9beta-D-Ribofuranoside
Adenine-9beta-delta-Ribofuranoside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosina
Adenosine
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine, homopolymer
Adenosinum
Adensoine
Adenyldeoxyriboside
Ado
Adénosine
BB_NC-0565
BSPBio_001796
Bio1_000437
 
Bio1_000926
Bio1_001415
Boniton
C00212
CCRIS 2557
CHEBI:16335
CHEMBL477
CID60961
Caswell No. 010B
D000241
D00045
DB00640
Deoxyadenosine
Desoxyadenosine
EA6C60C2-6AFB-4264-A2F0-541373DB950E
EINECS 200-389-9
FT-0082881
HMS1920A13
HMS2091G13
KBio3_001296
LS-15085
MEDR-640
MLS000069638
MLS002153227
MolPort-001-838-229
Myocol
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NSC 627048
NSC 7652
NSC627048
NSC7652
Nucleocardyl
Pallacor
Polyadenosine
Polyriboadenosine
S1647_Selleck
SDCCGMLS-0003108.P003
SMR000058216
SPBio_001194
SPECTRUM1500107
SR 96225
SR-96225
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum3_000288
TL8003749
UNII-K72T3FS567
USAF CB-10
V0098
Vidarabine
ZINC02169830
adenine-D-ribose
adenosine
b-D-Adenosine
beta-Adenosine
beta-D-Adenosine
beta-D-Ribofuranoside, adenine-9
beta-delta-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.2007.56-comp13
nchembio.64-comp4
nchembio706-5
22Antihypertensive AgentsPhase 23618
23Neurotransmitter AgentsPhase 214795
24Peripheral Nervous System AgentsPhase 218510
25Purinergic P1 Receptor AgonistsPhase 2131
26Adrenergic alpha-AgonistsPhase 21300
27Anti-Arrhythmia AgentsPhase 22371
28Adrenergic AgentsPhase 24204
29Adrenergic AgonistsPhase 22331
30AnalgesicsPhase 29358
31Adrenergic alpha-2 Receptor AgonistsPhase 2790
32AnticonvulsantsPhase 22249
33NeurotropinPhase 24
34Immunosuppressive AgentsPhase 210422
35Adjuvants, ImmunologicPhase 21783
36Anti-Infective AgentsPhase 217220
37Angiogenesis Modulating AgentsPhase 23611
38Angiogenesis InhibitorsPhase 23688
39Anti-Bacterial AgentsPhase 29140
40
Pregabalinapproved, illicit, investigational340148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
41Anesthetics7385
42Central Nervous System Depressants10016
43Contraceptives, Oral3734
44Tranquilizing Agents3597
45Psychotropic Drugs5501
46Anti-Anxiety Agents1529
47Calcium, Dietary4678
48calcium channel blockers1743

Interventional clinical trials:

(show all 28)
idNameStatusNCT IDPhase
1Prophylactic Administration of Vitamin C in Wrist FracturesCompletedNCT00296868Phase 4
2Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal WomenCompletedNCT00239889Phase 4
3A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1CompletedNCT00166452Phase 3
4Pain Exposure Physical Therapy (PEPT) Versus CBO in Patients With Complex Regional Pain Syndrome Type I (CRPS-1)CompletedNCT00817128Phase 2, Phase 3
5A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1RecruitingNCT02504008Phase 3
6Efficacy and Safety of Intravenous Neridronic Acid in CRPS-IActive, not recruitingNCT02402530Phase 2, Phase 3
7Intravenous Immunoglobulins in Complex-regional Pain SyndromeNot yet recruitingNCT00949065Phase 3
8Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb SurgeryNot yet recruitingNCT02390505Phase 3
9A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)CompletedNCT00067743Phase 2
10Clonidine Versus Adenosine to Treat Neuropathic PainCompletedNCT00349921Phase 2
11Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1TerminatedNCT00109772Phase 2
12Neurotropin to Treat Chronic Neuropathic PainTerminatedNCT00006289Phase 2
13Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.RecruitingNCT02321566Phase 1
14The Rubber Hand Illusion (RHI) in Patients With CRPSCompletedNCT01618578
15Graded Exposure (GEXP) in Vivo Versus Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I)CompletedNCT00625976
16Near-infrared Spectroscopic Measurement in Complex Regional Pain SyndromeCompletedNCT01586377
17Correlation Between 3 Phase Bone Scintigraphy and Pressure Pain Thresholds in Patients With Complex Regional Pain Syndrome (CRPS)CompletedNCT01623141
18Effects of Repetitive Electric Sensory Stimulation (RSS) as Intervention in Complex-regional-pain-syndrome Type I (CRPS)RecruitingNCT01915329
19Neurophysiological Basis of Rehabilitation in Complex Regional Pain Syndrome, Type I and Chronic Low Back PainRecruitingNCT02347579
20Association of Transcutaneous Electrical Nerve Stimulation and HypnosisRecruitingNCT01944150
21Two Measures of Tactile Acuity in CRPS Type I PatientsRecruitingNCT01888783
22Multi-disciplinary Prevention ProgramRecruitingNCT02563431
23Investigation of the Efficacy of tDCS in the Treatment of Complex Regional Pain Syndrome (CRPS) Type 1Active, not recruitingNCT01960400
24Regional Anesthesia Military Battlefield Pain Outcomes StudyActive, not recruitingNCT00431847
25The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle FractureNot yet recruitingNCT01338129
26The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic NeuropathyNot yet recruitingNCT00815932
27Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)TerminatedNCT00891397
28Single-port Thoracoscopic Sympathicotomy in Complex Regional Pain Syndrome Type I (CRPS)WithdrawnNCT01886625

Search NIH Clinical Center for Complex Regional Pain Syndrome Type 1

Genetic Tests for Complex Regional Pain Syndrome Type 1

About this section

Anatomical Context for Complex Regional Pain Syndrome Type 1

About this section

MalaCards organs/tissues related to Complex Regional Pain Syndrome Type 1:

33
Bone, Cortex, Prostate, Breast, Heart, Kidney, Liver

Animal Models for Complex Regional Pain Syndrome Type 1 or affiliated genes

About this section

Publications for Complex Regional Pain Syndrome Type 1

About this section

Articles related to Complex Regional Pain Syndrome Type 1:

(show top 50)    (show all 100)
idTitleAuthorsYear
1
Insulin-like growth factor 1 promotes growth of gastric cancer by inhibiting foxo1 nuclear retention. (25596089)
2015
2
Malignant transformation of breast ductal adenoma: a diagnostic pitfall. (26712676)
2015
3
Diagnosis of extra-adrenal phaeochromocytoma after nephrectomy. (25140231)
2014
4
Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution. (25311849)
2014
5
Pigmented villonodular synovitis on lumbar spine : a case report and literature review. (25368775)
2014
6
Amyopathic dermatomyositis complicated by pneumomediastinum. (23556036)
2013
7
Rhein protects against obesity and related metabolic disorders through liver X receptor-mediated uncoupling protein 1 upregulation in brown adipose tissue. (23139635)
2012
8
The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions. (22257824)
2012
9
Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. (20335060)
2010
10
Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats. (20124930)
2010
11
Hormonal therapy for prostate cancer: toward further unraveling of androgen receptor function. (19719456)
2009
12
Three-dimensional computed tomography analysis of non-osteoarthritic adult acetabular dysplasia. (18830593)
2009
13
Genetic and environmental influence on attachment disorganization. (19673052)
2009
14
Epidemiology of urogenital tuberculosis worldwide. (18637157)
2008
15
An iron responsive element-like stem-loop regulates alpha-hemoglobin-stabilizing protein mRNA. (18676996)
2008
16
What is your diagnosis? Acquired acrodermatitis enteropathica. (18491477)
2008
17
Alterations in calcium regulatory protein expression in patients with preserved left ventricle systolic function and mitral valve stenosis. (19041052)
2008
18
Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation. (18292509)
2008
19
NYD-SP18 is associated with obesity in the NHLBI Family Heart Study. (18317470)
2008
20
Genetic inactivation of the laminin alpha5 chain receptor Lu/BCAM leads to kidney and intestinal abnormalities in the mouse. (18032551)
2008
21
Elevated plasma adiponectin and leptin levels in sisters with genetically defective insulin receptors. (17965293)
2007
22
Prevalence, severity and predictors of HOMA-estimated insulin resistance in diabetic and nondiabetic patients with end-stage renal disease. (17136689)
2006
23
Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin. (16287083)
2006
24
Candida laryngitis. (16949990)
2006
25
Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women. (15998377)
2005
26
Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. (15914297)
2005
27
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. (16322239)
2005
28
In vitro transcription of the Listeria monocytogenes virulence genes inlC and mpl reveals overlapping PrfA-dependent and -independent promoters that are differentially activated by GTP. (15049809)
2004
29
Live cell imaging of Gs and the beta2-adrenergic receptor demonstrates that both alphas and beta1gamma7 internalize upon stimulation and exhibit similar trafficking patterns that differ from that of the beta2-adrenergic receptor. (15297467)
2004
30
Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. (15388725)
2004
31
Nuclear factor-kappa B activation in the nasal polyp epithelium: relationship to local cytokine gene expression. (11802038)
2002
32
Androgens and increased lipogenesis in prostate cancer. Cell biologic and clinical perspectives]. (12238242)
2002
33
Novel CLCN1 mutations with unique clinical and electrophysiological consequences. (12390967)
2002
34
Anemia in pregnancy in rural Tanzania: associations with micronutrients status and infections. (11960293)
2002
35
Induction of bone formation by recombinant human osteogenic protein-1 and sintered porous hydroxyapatite in adult primates. (11252092)
2001
36
Lobar pulmonary interstitial emphysema in a premature infant on continuous positive airway pressure using nasal prongs. (11317654)
2001
37
Private beta- and gamma-sarcoglycan gene mutations: evidence of a founder effect in Northern Italy. (10874299)
2000
38
Mucinous carcinoma of the breast with neuroendocrine differentiation. (10972863)
2000
39
A protein phosphatase functions to recycle RNA polymerase II. (10385623)
1999
40
Modulation of guinea-pig cardiac L-type calcium current by nitric oxide synthase inhibitors. (9503327)
1998
41
Binding of phosphate and sulfate anions by purine nucleoside phosphorylase from E. coli: ligand-dependent quenching of enzyme intrinsic fluorescence. (9108686)
1997
42
Frequent jumping translocations of chromosomal segments involving the ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias. (9002963)
1997
43
Hepatocyte nuclear factor 3beta participates in the transcriptional regulation of the thyroperoxidase promoter. (8602863)
1996
44
Augmentation by aphidicolin of 1-beta-D-arabinofuranosylcytosine-induced c-jun and NF-kappa B activation in a human myeloid leukemia cell line: correlation with apoptosis. (7564475)
1995
45
Mechanisms regulating Raf-1 activity in signal transduction pathways. (8607983)
1995
46
Solid-phase antibody capture hemadsorption assay for detection of hepatitis A virus immunoglobulin M antibodies. (8388890)
1993
47
Dermatitis herpetiformis: gastrointestinal association. (1806219)
1991
48
Indirect videolaryngoscopy versus direct endoscopy for larynx and pharynx cancer staging. Toward elimination of preliminary direct laryngoscopy. (2782803)
1989
49
Food-dependent, exercise-induced anaphylaxis. (6644976)
1983
50
Coronary and aortic atherosclerosis in New Orleans. II. Comparison of lesions by age, sex, and race. (703259)
1978

Variations for Complex Regional Pain Syndrome Type 1

About this section

Expression for genes affiliated with Complex Regional Pain Syndrome Type 1

About this section
Search GEO for disease gene expression data for Complex Regional Pain Syndrome Type 1.

Pathways for genes affiliated with Complex Regional Pain Syndrome Type 1

About this section

Pathways related to Complex Regional Pain Syndrome Type 1 according to GeneCards Suite gene sharing:

(show all 17)
idSuper pathwaysScoreTop Affiliating Genes
19.6IL6, TNF
29.6IL6, TNF
39.6IL6, TNF
49.6IL6, TNF
59.6IL6, TNF
69.6IL6, TNF
79.6IL6, TNF
89.6IL6, TNF
99.3CALCA, EDN1
109.1CXCL9, CXCR3
119.1CALCA, IL6, TNF
12
Show member pathways
9.1CXCL9, IL6, TNF
139.0EDN1, IL6, TNF
149.0EDN1, IL6, TNF
15
Show member pathways
8.3CXCL9, CXCR3, IL6, TNF
16
Show member pathways
7.6CXCL9, CXCR3, EDN1, IL6, TNF
17
Show member pathways
7.1CALCA, CXCL9, CXCR3, EDN1, IL6, TNF

GO Terms for genes affiliated with Complex Regional Pain Syndrome Type 1

About this section

Cellular components related to Complex Regional Pain Syndrome Type 1 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.2CXCR3, IL6

Biological processes related to Complex Regional Pain Syndrome Type 1 according to GeneCards Suite gene sharing:

(show all 29)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.3IL6, TNF
2negative regulation of lipid storageGO:001088810.2IL6, TNF
3defense response to Gram-positive bacteriumGO:005083010.2IL6, TNF
4negative regulation of fat cell differentiationGO:004559910.1IL6, TNF
5response to glucocorticoidGO:005138410.1IL6, TNF
6positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.1IL6, TNF
7positive regulation of peptidyl-serine phosphorylationGO:003313810.1IL6, TNF
8positive regulation of protein kinase B signalingGO:005189710.1IL6, TNF
9response to yeastGO:000187810.0CALCA, IL6
10positive regulation of MAP kinase activityGO:004340610.0EDN1, TNF
11negative regulation of hormone secretionGO:004688810.0EDN1, IL6
12positive regulation of interleukin-6 productionGO:00327559.9IL6, TNF
13response to amino acidGO:00432009.9EDN1, IL6
14positive regulation of apoptotic processGO:00430659.9IL6, TNF
15cell growthGO:00160499.9EDN1, IL6
16defense response to Gram-negative bacteriumGO:00508299.9CALCA, IL6
17monocyte chemotaxisGO:00025489.8CALCA, IL6
18cellular response to interleukin-1GO:00713479.8EDN1, IL6
19positive regulation of leukocyte chemotaxisGO:00026909.8CXCL9, IL6
20positive regulation of nitric oxide biosynthetic processGO:00454299.6EDN1, IL6, TNF
21positive regulation of JUN kinase activityGO:00435079.5EDN1, TNF
22positive regulation of smooth muscle cell proliferationGO:00486619.4EDN1, IL6, TNF
23cellular response to tumor necrosis factorGO:00713569.4CALCA, IL6
24immune responseGO:00069559.3CXCL9, IL6, TNF
25cell-cell signalingGO:00072679.1CALCA, CXCL9, EDN1
26cell surface receptor signaling pathwayGO:00071669.0CXCR3, EDN1, TNF
27response to lipopolysaccharideGO:00324968.9CXCL9, EDN1, IL6
28inflammatory responseGO:00069548.8CALCA, CXCL9, IL6, TNF
29positive regulation of transcription from RNA polymerase II promoterGO:00459447.9CXCR3, EDN1, IL6, TNF

Sources for Complex Regional Pain Syndrome Type 1

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet